Endocrine Abstracts

Introduction: Papillary thyroid carcinoma (PTC) is a common thyroid gland malignancy. Postoperative suppression therapy with levothyroxine (LT4) is commonly used to prevent recurrence or progression of the disease. The optimal duration and dose of LT4 suppression therapy remain a matter of debate. The optimal duration and dose of LT4 suppression therapy remain a matter of debate, with recommendations varying based on the patient’s age, sex, tumor characteristics, and risk...

Introduction: Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) is an encapsulated or well-defined, not invasive neoplasm with a follicular growth pattern and core features of papillary thyroid carcinoma (PTC). This is considered to be a ’pre-malignant’ lesion of the RAS-like group. The RAS oncogene plays a huge role in human tumorigenesis. RAS gene mutations occur, in an average of 30–45% of follicular thyroid cancers (FTC). A...